SKIN SkinHealth Systems Inc.
Company Analysis
Latest News
SkinHealth Systems Announces Resignation of Chief Operating Officer Sheri Lewis
SkinHealth Systems Inc. announced that Sheri Lewis, its Chief Operations, Quality and Technology Officer, has resigned to pursue other business opportunities....
SkinHealth Systems' second quarter 2026 revenue missed expectations despite a margin-driven adjusted EBITDA beat
SkinHealth Systems reported mixed second quarter results as top-line sales felt the impact of distributor transitions and lower system placements. While total...
Beauty Health Co Q2 2026 Earnings Preview: What Analysts Expect on August 06, 2026
Analysts anticipate Beauty Health Co (recently rebranded to SkinHealth Systems) will report Q2 2026 revenue of $74.45 million and a loss per share of $0.04, as...
🔴 Beauty Health is trading 10.5% down
Beauty Health is trading at $0.94, down 10.5% from a comparison close of $1.05 during regular trading. This is a price-action follow-up, so a separate catalyst...
🔴 Beauty Health is trading 5.6% down today amid ongoing speculative volatility
Beauty Health is trading at $0.99 (5.6% down) as the stock continues to experience sharp price fluctuations following a period of intense trading activity. •...
🟢 Beauty Health is trading 6.7% up today amid continued speculative volatility
Beauty Health is trading at $1.12, up 6.7% today, as the stock continues to experience sharp price swings without clear fundamental drivers. • The stock has...
🔴 SKIN makes sharp 10.4% drop
SKIN is trading at $0.99, down 10.4% versus the comparison close of $1.11 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 SKIN is trading 5.2% down today on profit-taking after its recent FDA-driven surge
SKIN is trading at $1.05 (-5.23%) as investors lock in gains following a sharp rally triggered by FDA clearance for its SkinStylus device. • The stock...
🔴 SKIN is trading 1.8% down today on profit-taking following its FDA-driven surge
SKIN is trading 1.8% down at $1.09 as the stock experiences a sharp pullback following its recent regulatory-driven rally. • The stock previously surged...
🔴 SKIN is trading 6.3% down today on profit-taking after FDA-driven surge
SKIN is trading 6.3% down at $1.04 as the stock undergoes a pre-market pullback following a significant FDA-driven rally. • The stock surged 47.04% to $1.11...
🔴 SKIN is trading 5% down today after FDA clearance-driven surge
SKIN is trading 5% down at $1.05 in after-hours trading after a sharp regular-session rally triggered by FDA clearance for its wrinkle treatment system. • The...
🟢 SKIN Surges 40% on New FDA Clearance for SkinStylus
SKIN is trading 40% up at $1.06 today after its SkinStylus SteriLock MicroSystem received new FDA clearance for the improvement of periorbital wrinkles for all...